Paychex Inc. (PAYX) Insider Trading

Last 12 months

Insiders bought $197k and sold $4.62M on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Martin Mucci sold $2.75M on Jul 14, 5.3% of their stake, outside a plan.

Net open-market

−$4.42M

2 buys · 6 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

2 / 6

executives and directors

Last open-market buy

Feb 2026

Feb 4, 2026

Get an email when PAYX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 14	Joseph M Velli Director	SoldNo plan	7,839	$107.68	$844k	8.7%	Form 4
Jul 20	Robert L. Schrader Sr. VP, CFO	SoldNo plan	2,600	$115.09	$299k	12%	Form 4
Jul 17	Christopher C Simmons VP, Controller & Treasurer	SoldNo plan	2,615	$115.92	$303k	43%	Form 4
Jul 14	Martin Mucci Director	SoldNo plan	25,000	$109.93	$2.75M	5.3%	Form 4
Jun 26	Joseph M Tucci Director	SoldNo plan	3,907	$98.25	$384k	5.5%	Form 4
May 13	Elizabeth Roaldsen Sr. Vice President	SoldNo plan	459	$90.00	$41k	4.7%	Form 4
Feb 4	Joseph Doody Director	Bought	1,000	$98.76	$99k	4.1%	Form 4
Feb 4	Tom Bonadio Director	Bought	1,000	$98.50	$99k	4.9%	Form 4
Jul 16, 2025	Christopher C Simmons VP, Controller & Treasurer	SoldNo plan	1,843	$140.98	$260k	24%	Form 4
Jul 16, 2025	Robert L. Schrader Sr. VP, CFO	SoldNo plan	3,160	$140.63	$444k	14%	Form 4
Jul 16, 2025	John B Gibson President and CEO	SoldNo plan	12,370	$141.92	$1.76M	13%	Form 4
Jul 10, 2025	Martin Mucci Director	SoldNo plan	97,526	$145.17	$14.2M	18%	Form 4
Apr 15, 2025	Joseph M Velli Director	SoldNo plan	3,650	$149.25	$545k	4.4%	Form 4
Apr 3, 2025	Michael E Gioja Sr. Vice President	SoldNo plan 2 parts	31,653	$154.59 average	$4.89M	57%	Form 4

Oct 14No plan
Joseph M Velli
Director · sold 7,839 at $107.68
$844k
8.7% of stake
Jul 20No plan
Robert L. Schrader
Sr. VP, CFO · sold 2,600 at $115.09
$299k
12% of stake
Jul 17No plan
Christopher C Simmons
VP, Controller & Treasurer · sold 2,615 at $115.92
$303k
43% of stake
Jul 14No plan
Martin Mucci
Director · sold 25,000 at $109.93
$2.75M
5.3% of stake
Jun 26No plan
Joseph M Tucci
Director · sold 3,907 at $98.25
$384k
5.5% of stake
May 13No plan
Elizabeth Roaldsen
Sr. Vice President · sold 459 at $90.00
$41k
4.7% of stake
Feb 4
Joseph Doody
Director · bought 1,000 at $98.76
$99k
4.1% of stake
Feb 4
Tom Bonadio
Director · bought 1,000 at $98.50
$99k
4.9% of stake
Jul 16, 2025No plan
Christopher C Simmons
VP, Controller & Treasurer · sold 1,843 at $140.98
$260k
24% of stake
Jul 16, 2025No plan
Robert L. Schrader
Sr. VP, CFO · sold 3,160 at $140.63
$444k
14% of stake
Jul 16, 2025No plan
John B Gibson
President and CEO · sold 12,370 at $141.92
$1.76M
13% of stake
Jul 10, 2025No plan
Martin Mucci
Director · sold 97,526 at $145.17
$14.2M
18% of stake
Apr 15, 2025No plan
Joseph M Velli
Director · sold 3,650 at $149.25
$545k
4.4% of stake
Apr 3, 2025No plan
Michael E Gioja
Sr. Vice President · sold 31,653 at avg $154.59
$4.89M
57% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PAYX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Engineering, Accounting, Research, Management

ITGartner Inc.

INCYIncyte Corporation

GGenpact Ltd.

TTEKTetra Tech, Inc.

VVXV2X Inc.

CRLCharles River Laboratories International, Inc.

FCNFti Consulting Inc.

ASTHAstrana Health Inc.

Spot a number that looks wrong? Check it in PAYX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PAYX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.